Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
45°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Mural Oncology, Inc.
Mural Oncology to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
October 07, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 02, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
Mural Oncology’s First Virtual Investor Day to Highlight Late-Stage Clinical Progress
September 26, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
Mural Oncology Strengthens Board of Directors with the Appointment of Sachiyo Minegishi
September 23, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
Mural Oncology to Host First Virtual Investor Day on September 26, 2024
September 10, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 04, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
Mural Oncology to Present at Two Upcoming Investor Conferences
August 27, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress
August 13, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 02, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors
July 31, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 02, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference
June 05, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 04, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
May 23, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update
May 14, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
April 09, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 04, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
March 26, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
March 05, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 04, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference
February 27, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 05, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
Mural Oncology Announces Enhancements to Late-Stage Clinical Trials
January 08, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Tickers
MURA
Mural Oncology Launches to Advance Pipeline of Novel Engineered Cytokine Immunotherapies
November 15, 2023
From
Mural Oncology, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.